Titre : Troubles du contrôle des impulsions

Troubles du contrôle des impulsions : Questions médicales fréquentes

Termes MeSH sélectionnés :

Visual Fields
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Troubles du contrôle des impulsions : Questions médicales les plus fréquentes", "headline": "Troubles du contrôle des impulsions : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Troubles du contrôle des impulsions : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-17", "dateModified": "2025-04-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Troubles du contrôle des impulsions" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Troubles mentaux", "url": "https://questionsmedicales.fr/mesh/D001523", "about": { "@type": "MedicalCondition", "name": "Troubles mentaux", "code": { "@type": "MedicalCode", "code": "D001523", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Pyromanie", "alternateName": "Firesetting Behavior", "url": "https://questionsmedicales.fr/mesh/D005391", "about": { "@type": "MedicalCondition", "name": "Pyromanie", "code": { "@type": "MedicalCode", "code": "D005391", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.250.300" } } }, { "@type": "MedicalWebPage", "name": "Jeu de hasard", "alternateName": "Gambling", "url": "https://questionsmedicales.fr/mesh/D005715", "about": { "@type": "MedicalCondition", "name": "Jeu de hasard", "code": { "@type": "MedicalCode", "code": "D005715", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.250.400" } } }, { "@type": "MedicalWebPage", "name": "Trichotillomanie", "alternateName": "Trichotillomania", "url": "https://questionsmedicales.fr/mesh/D014256", "about": { "@type": "MedicalCondition", "name": "Trichotillomanie", "code": { "@type": "MedicalCode", "code": "D014256", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F03.250.800" } } } ], "about": { "@type": "MedicalCondition", "name": "Troubles du contrôle des impulsions", "alternateName": "Disruptive, Impulse Control, and Conduct Disorders", "code": { "@type": "MedicalCode", "code": "D007174", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "23andMe, Sunnyvale, California, USA." } }, { "@type": "Person", "name": "Ana Marques", "url": "https://questionsmedicales.fr/author/Ana%20Marques", "affiliation": { "@type": "Organization", "name": "EA 7280 Laboratory of Neuropychopharmacology of the Subcortical Dopaminergic Systems, UFR Medecine, Université Clermont Auvergne, Clermont-Ferrand, France." } }, { "@type": "Person", "name": "Pedro M Paz-Alonso", "url": "https://questionsmedicales.fr/author/Pedro%20M%20Paz-Alonso", "affiliation": { "@type": "Organization", "name": "Basque Center on Cognition, Brain and Language (BCBL), San Sebastián, Spain. Electronic address: p.pazalonso@bcbl.eu." } }, { "@type": "Person", "name": "Manuel Delgado-Alvarado", "url": "https://questionsmedicales.fr/author/Manuel%20Delgado-Alvarado", "affiliation": { "@type": "Organization", "name": "Neurodegenerative Disorders Area, Biodonostia Health Research Institute, San Sebastián, Spain; Neurology Department, Sierrallana Hospital, Torrelavega, Spain; IDIVAL, Valdecilla Biomedical Research Institute, Santander, Spain; Biomedical Research Networking Center for Mental Health (CIBERSAM), Madrid, Spain. Electronic address: manueldelgadoalv@gmail.com." } }, { "@type": "Person", "name": "Maria Livia Fantini", "url": "https://questionsmedicales.fr/author/Maria%20Livia%20Fantini", "affiliation": { "@type": "Organization", "name": "EA 7280 Laboratory of Neuropychopharmacology of the Subcortical Dopaminergic Systems, UFR Medecine, Université Clermont Auvergne, Clermont-Ferrand, France. mfantini@chu-clermontferrand.fr." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Humphrey visual field made easy for residents.", "datePublished": "2024-09-27", "url": "https://questionsmedicales.fr/article/39331457", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.4103/IJO.IJO_2519_23" } }, { "@type": "ScholarlyArticle", "name": "Detection of post-stroke visual field loss by quantification of the retrogeniculate visual pathway.", "datePublished": "2022-05-27", "url": "https://questionsmedicales.fr/article/35640329", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jns.2022.120297" } }, { "@type": "ScholarlyArticle", "name": "Foveal avascular zone vessel density is associated with visual field progression in early-stage glaucoma eyes with central visual field damage.", "datePublished": "2023-10-25", "url": "https://questionsmedicales.fr/article/37880406", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-023-45541-1" } }, { "@type": "ScholarlyArticle", "name": "Visual feedback in the lower visual field affects postural control during static standing.", "datePublished": "2022-07-08", "url": "https://questionsmedicales.fr/article/35843008", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.gaitpost.2022.07.004" } }, { "@type": "ScholarlyArticle", "name": "Five-Year Visual Field Outcomes of the HORIZON Trial.", "datePublished": "2023-02-21", "url": "https://questionsmedicales.fr/article/36813144", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ajo.2023.02.008" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Troubles mentaux", "item": "https://questionsmedicales.fr/mesh/D001523" }, { "@type": "ListItem", "position": 3, "name": "Troubles du contrôle des impulsions", "item": "https://questionsmedicales.fr/mesh/D007174" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Troubles du contrôle des impulsions - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Troubles du contrôle des impulsions", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Troubles du contrôle des impulsions", "description": "Comment diagnostique-t-on un trouble du contrôle des impulsions ?\nQuels critères sont utilisés pour le diagnostic ?\nLes tests psychologiques sont-ils nécessaires ?\nQui peut poser le diagnostic ?\nLes antécédents familiaux influencent-ils le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D007174?mesh_terms=Visual+Fields&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Troubles du contrôle des impulsions", "description": "Quels sont les symptômes courants des troubles du contrôle des impulsions ?\nComment se manifeste l'impulsivité ?\nY a-t-il des signes d'alerte précoce ?\nLes troubles de l'humeur sont-ils liés ?\nLes symptômes varient-ils selon l'âge ?", "url": "https://questionsmedicales.fr/mesh/D007174?mesh_terms=Visual+Fields&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Troubles du contrôle des impulsions", "description": "Peut-on prévenir les troubles du contrôle des impulsions ?\nQuel rôle joue l'éducation dans la prévention ?\nLes programmes de sensibilisation sont-ils efficaces ?\nComment les parents peuvent-ils aider ?\nLe soutien scolaire joue-t-il un rôle ?", "url": "https://questionsmedicales.fr/mesh/D007174?mesh_terms=Visual+Fields&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Troubles du contrôle des impulsions", "description": "Quels traitements sont disponibles pour ces troubles ?\nLa thérapie cognitive est-elle efficace ?\nLes médicaments peuvent-ils aider ?\nLa thérapie de groupe est-elle bénéfique ?\nCombien de temps dure le traitement ?", "url": "https://questionsmedicales.fr/mesh/D007174?mesh_terms=Visual+Fields&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Troubles du contrôle des impulsions", "description": "Quelles complications peuvent survenir ?\nLes troubles de l'humeur sont-ils des complications possibles ?\nComment les comportements à risque affectent-ils la vie ?\nLes relations sociales sont-elles affectées ?\nY a-t-il un risque accru de toxicomanie ?", "url": "https://questionsmedicales.fr/mesh/D007174?mesh_terms=Visual+Fields&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Troubles du contrôle des impulsions", "description": "Quels sont les facteurs de risque principaux ?\nLe stress peut-il aggraver ces troubles ?\nL'environnement familial joue-t-il un rôle ?\nLes troubles de l'attention sont-ils un facteur de risque ?\nL'âge d'apparition influence-t-il le risque ?", "url": "https://questionsmedicales.fr/mesh/D007174?mesh_terms=Visual+Fields&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on un trouble du contrôle des impulsions ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'évaluation clinique des symptômes et l'historique du patient." } }, { "@type": "Question", "name": "Quels critères sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les critères incluent des comportements impulsifs récurrents et des conséquences négatives." } }, { "@type": "Question", "name": "Les tests psychologiques sont-ils nécessaires ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des tests peuvent être utilisés pour évaluer la gravité des symptômes et l'impact fonctionnel." } }, { "@type": "Question", "name": "Qui peut poser le diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Un psychiatre ou un psychologue qualifié peut poser le diagnostic après évaluation." } }, { "@type": "Question", "name": "Les antécédents familiaux influencent-ils le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antécédents familiaux de troubles mentaux peuvent être un facteur de risque." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des troubles du contrôle des impulsions ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent l'agressivité, l'irritabilité et des comportements destructeurs." } }, { "@type": "Question", "name": "Comment se manifeste l'impulsivité ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "L'impulsivité se manifeste par des actions sans réflexion préalable, souvent regrettées après." } }, { "@type": "Question", "name": "Y a-t-il des signes d'alerte précoce ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme des accès de colère fréquents ou des comportements à risque peuvent alerter." } }, { "@type": "Question", "name": "Les troubles de l'humeur sont-ils liés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les troubles de l'humeur peuvent coexister avec des troubles du contrôle des impulsions." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en fonction de l'âge et du développement psychologique." } }, { "@type": "Question", "name": "Peut-on prévenir les troubles du contrôle des impulsions ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention est possible par l'éducation et le soutien émotionnel dès le jeune âge." } }, { "@type": "Question", "name": "Quel rôle joue l'éducation dans la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "L'éducation aide à développer des compétences de gestion des émotions et des comportements." } }, { "@type": "Question", "name": "Les programmes de sensibilisation sont-ils efficaces ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les programmes de sensibilisation peuvent réduire les comportements à risque chez les jeunes." } }, { "@type": "Question", "name": "Comment les parents peuvent-ils aider ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les parents peuvent aider en établissant des règles claires et en offrant un soutien affectif." } }, { "@type": "Question", "name": "Le soutien scolaire joue-t-il un rôle ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un soutien scolaire adéquat peut aider à prévenir les comportements impulsifs chez les enfants." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour ces troubles ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la thérapie comportementale et, parfois, des médicaments." } }, { "@type": "Question", "name": "La thérapie cognitive est-elle efficace ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la thérapie cognitive aide à modifier les pensées et comportements impulsifs." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments comme les antidépresseurs peuvent être prescrits pour réduire les symptômes." } }, { "@type": "Question", "name": "La thérapie de groupe est-elle bénéfique ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la thérapie de groupe offre un soutien et des stratégies de gestion des impulsions." } }, { "@type": "Question", "name": "Combien de temps dure le traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La durée du traitement varie selon la gravité des symptômes et la réponse au traitement." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des problèmes relationnels, juridiques et des troubles associés." } }, { "@type": "Question", "name": "Les troubles de l'humeur sont-ils des complications possibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les troubles de l'humeur comme la dépression peuvent survenir en raison de l'impulsivité." } }, { "@type": "Question", "name": "Comment les comportements à risque affectent-ils la vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les comportements à risque peuvent entraîner des blessures, des problèmes juridiques et des regrets." } }, { "@type": "Question", "name": "Les relations sociales sont-elles affectées ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les troubles du contrôle des impulsions peuvent nuire aux relations interpersonnelles." } }, { "@type": "Question", "name": "Y a-t-il un risque accru de toxicomanie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes avec ces troubles peuvent avoir un risque accru de développer des addictions." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque principaux ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des traumatismes et des troubles mentaux." } }, { "@type": "Question", "name": "Le stress peut-il aggraver ces troubles ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut exacerber les symptômes des troubles du contrôle des impulsions." } }, { "@type": "Question", "name": "L'environnement familial joue-t-il un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un environnement familial instable peut augmenter le risque de développer ces troubles." } }, { "@type": "Question", "name": "Les troubles de l'attention sont-ils un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les troubles de l'attention peuvent coexister et augmenter le risque d'impulsivité." } }, { "@type": "Question", "name": "L'âge d'apparition influence-t-il le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une apparition précoce des symptômes peut indiquer un risque accru de complications." } } ] } ] }

Sources (10000 au total)

Humphrey visual field made easy for residents.

Visual field testing is an indispensable part of the assessment of glaucoma. Of paramount importance to both the practitioner and the perimetrist is the guidance on how to conduct the test to get the ... To simplify the basics of understanding single-field analysis of visual field tests by using the Humphrey perimeter.... The general principle and a brief overview of how the Humphrey visual field is conducted and the approach to interpreting the results of single field analysis in an easy-to-understand manner are prese... This educational video is an attempt to simplify the interpretation of Humphrey visual field single-field analysis with illustrations and video clips that would be useful to practicing ophthalmologist... https://youtu.be/x8iZLDR4XdY....

Foveal avascular zone vessel density is associated with visual field progression in early-stage glaucoma eyes with central visual field damage.

We investigated the relationship between foveal avascular zone (FAZ)-related parameters, assessed by optical coherence tomography angiography (OCT-A), and visual field (VF) progression in early-stage ...

Visual feedback in the lower visual field affects postural control during static standing.

The dorsal parietal visual system plays an important role in self-motion perception and spatial cognition. It also strongly responds to visual inputs from the lower visual field. Postural control is m... Do visual stimuli presented to the lower and upper visual fields affect postural control and sensory reweighting?... Twenty-nine healthy young adults participated in the study. Four conditions (full visual field, upper visual field, lower visual field, and no optic flow condition) were simulated in a VR environment ... Optic flow in the full and lower visual fields produced significantly smaller 95 % ellipse area and RMS of COP in the anterior-posterior direction compared to optic flow in the upper visual field. Furth... Visual feedback affects static postural control more when presented in the lower visual field compared to the upper visual field....

Five-Year Visual Field Outcomes of the HORIZON Trial.

To compare visual field (VF) progression between glaucoma patients receiving cataract surgery alone (CS) or with a Hydrus microstent (CS-HMS).... Post hoc analysis of VF data from the HORIZON multicenter randomized controlled trial.... A total of 556 patients with glaucoma and cataract were randomized 2:1 to either CS-HMS (369) or CS (187) and followed up for 5 years. VF was performed at 6 months and then every year after surgery. W... Data from 352 eyes in the CS-HMS arm and 165 in the CS arm were analyzed (2966 VFs). The mean RoP was -0.26 dB/y (95% credible interval -0.36, -0.16) for CS-HMS and -0.49 dB/y (95% credible interval -... CS-HMS has a significant effect on VF preservation in glaucoma patients compared with CS alone, reducing the proportion of fast progressors....

Effect of trabeculectomy on the rate of progression of visual field damage.

This study quantifies the effect of trabeculectomy on the rate of progression (RoP) of visual field (VF) damage utilising pre- and post-operative visual function as the outcome instead of surrogate ou... Clinical and VF data from 199 sequential patients who underwent trabeculectomy between 2015 and 2016 were extracted from the network of sites of Moorfields Eye Hospital NHS Foundation Trust. Of these,... We analysed 10 [9,12] VFs per subject (Median [Interquartile Range]). At surgery, the age was 67 [57, 72] years, mean deviation was -10.84 [-14.7, -5.6] dB and the IOP was 18 [15, 20] mmHg. One year a... Trabeculectomy leads to a significant reduction in the RoP of VF loss postoperatively....

A Consensus Statement on the Terminology for Automated Visual Field Abnormalities.

A multitude of terms have been used to describe automated visual field abnormalities. To date, there is no universally accepted system of definitions or guidelines. Variability among clinicians create... In phase one of the study, all neuro-ophthalmologists in Israel were asked to complete a survey in which they described the abnormalities in 10 selected automated visual field tests. In phase 2 of the... Twenty-six neuro-ophthalmologists participated in the initial survey. On average, there were 7.5 unique descriptions for each of the visual fields (SD 3.17), a description of only the location in 24.6... The study confirmed a great degree of variability in the use of terminology to describe automated visual field abnormalities. The creation of a consensus statement was associated with improved use of ...

Gaze tracker parameters have little association with visual field metrics of intrasession frontloaded SITA-Faster 24-2 visual field results.

To determine the usefulness of Humphrey Field Analyser (HFA) SITA-Faster 24-2 gaze tracker outputs on interpreting intra-visit visual field (VF) result pairs.... Analysis of 1380 right-left eye pairs and 1432 pairs of test 1-test 2 intrasession VF results of patients seen within a university-based glaucoma service was undertaken to understand gaze deviation di... There was no association of test order (right-left, test 1-test 2) with eye movements. There was a significant, but weak correlation between eye movements and age (r = 0.16). Correlations of eye movem... Eye movement parameters as currently reported by the HFA do not appear to be correlated with key sensitivity parameters when considering the repeatability of intrasession SITA-Faster 24-2 VF results. ...

Peripheral visual field loss and activities of daily living.

Peripheral visual field (VF) loss affects 13% of the population over 65. Its effect on activities of daily living and higher order visual processing is as important as it is inadequately understood. T... In this review, glaucoma and retrochiasmal cortical damage are utilized as examples of peripheral field loss which typically spare central vision and have patterns respecting the horizontal and vertic... Peripheral VF loss is an under-recognized cause of patient distress and disability. All peripheral field loss is not the same, differential patterns of loss affect parameters of activities of daily li...